Senior Director, Population Health and Value Innovation

United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Devices, BiotechnologyIndustries

Requirements

The ideal candidate will have a proven track record in developing and executing value-based strategies that integrate health economics and outcomes research (HEOR), AI innovation, and payer policy insights. A strong understanding of healthcare policy trends, payer dynamics, and value-based care goals is essential, particularly concerning cardiovascular comorbid populations. Experience in designing and launching scalable population health programs, developing programmatic plays for market access and commercial teams, and leading real-world evidence generation is required. The role also demands expertise in AI strategy from a payer and provider utility perspective, aligning predictive modeling with operational programs and value-based payment models.

Responsibilities

The Senior Director, Global Value Access and Value Innovation will define, articulate, and deliver the clinical, economic, and technological value of iRhythm’s solutions to key stakeholders. This involves leading the integration of HEOR, market access strategy, real-world evidence, and AI innovation to drive adoption and reimbursement. Responsibilities include developing integrated value-based strategies, shaping the AI-enabled diagnostics roadmap, and translating healthcare policy into growth strategies. The role also entails designing and overseeing population health programs to expand market reach, creating programmatic plays for field teams, leading the generation of real-world evidence and economic data, and directing the company's AI strategy with a focus on payer and provider utility.

Skills

Population Health

Value Innovation

Health Economics and Outcomes Research (HEOR)

Market Access Strategy

Real-World Evidence

AI Innovation

Value-Based Care (VBC)

Payer Policy

Commercialization

Predictive Modeling

Strategic Leadership

iRhythm Technologies

Advanced cardiac monitoring solutions provider

About iRhythm Technologies

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring might miss, making it especially useful for patients at risk. The company serves both patients and healthcare providers, generating revenue by selling the Zio Patch and offering data analysis services to interpret the collected heart data. iRhythm aims to improve patient outcomes and streamline healthcare workflows in the cardiac health sector.

San Francisco, CaliforniaHeadquarters

2006Year Founded

$102.8MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees